Quest will provide research consulting, laboratory testing and data analytics services to generate diagnostics insights supporting population health strategy for hepatitis C

Quest将提供研究咨询、实验室测试和数据分析服务，以产生支持丙型肝炎人群健康战略的诊断见解

SECAUCUS, N.J., Dec. 7, 2023 /PRNewswire/ -- Quest Diagnostics (NYSE: DGX), the nation's leading provider of diagnostic information services, today announced that it has been awarded a contract by the United States Centers for Disease Control and Prevention (CDC) designed to assess the burden of hepatitis C virus (HCV) in the United States.

新泽西州塞考克斯，2023年12月7日，美国领先的诊断信息服务提供商Quest Diagnostics（纽约证券交易所：DGX）今天宣布，它已获得美国疾病控制和预防中心（CDC）的合同，旨在评估美国丙型肝炎病毒（HCV）的负担。

Quest was awarded a multi-year agreement following a competitive bid. The agreement marks a new phase of a decade-long collaboration between Quest and the CDC to improve hepatitis public health research based on insights from laboratory data. Under the new agreement, Quest will perform both HCV antibody testing and molecular RNA testing using HIPAA-deidentified 'remnant' specimens randomly selected from clinical test specimens.

在竞标后，Quest获得了一份多年期协议。该协议标志着Quest和CDC之间长达十年的合作进入了一个新阶段，旨在根据实验室数据的见解改进肝炎公共卫生研究。根据新协议，Quest将使用从临床测试样本中随机选择的HIPAA识别的“残余”样本进行HCV抗体测试和分子RNA测试。

The goal is to gain a better understanding of the burden of hepatitis C infection in the United States..

目的是更好地了解美国丙型肝炎感染的负担。。

'The longstanding collaboration between Quest and the CDC shows the power of strategic public-private collaborations to inform public health strategy in critical health areas,' said Harvey W. Kaufman, M.D., medical director and head of the Quest Diagnostics Health Trends® research program. 'Our prior work together with the CDC has shown substantial opportunity to improve care and treatment for individuals with hepatitis C, and we expect this additional research collaboration to build on that progress, informing public policy to reduce the incidence of hepatitis C in the United States.'.

医学博士哈维·W·考夫曼（HarveyW.Kaufman）是Quest Diagnostics health Trends®研究项目的医学总监和负责人，他说：“Quest与CDC之间的长期合作显示了战略性公私合作的力量，可以为关键健康领域的公共卫生战略提供信息。”我们之前与疾病预防控制中心的合作已经显示出改善丙型肝炎患者护理和治疗的巨大机会，我们期望这次额外的研究合作能够在这一进展的基础上，为公共政策提供信息，以降低美国丙型肝炎的发病率。”。

Prior agreements between Quest and the CDC involved analysis of laboratory results from tests ordered by healthcare providers for patients with suspected hepatitis infection. In 2013, the two organizations formed an agreement to jointly analyze de-identified hepatitis C testing data for 'Baby Boomers,' or individuals born from 1945 through 1965.

Quest和CDC之间的先前协议涉及对医疗保健提供者为疑似肝炎感染患者订购的测试的实验室结果进行分析。2013年，这两个组织达成协议，共同分析1945年至1965年出生的“婴儿潮一代”或个人的丙型肝炎检测数据。

Since 2012, Quest has supported the CDC to advance public health by providing deidentified laboratory results for hepatitis A, B, C and E. All shared laboratory test results are deidentified and HIPAA-compliant..

自2012年以来，Quest通过提供甲型、乙型、丙型和戊型肝炎的身份不明实验室结果，支持疾病预防控制中心促进公共卫生。所有共享的实验室检测结果都是身份不明且符合HIPAA的。。

Approximately 2 million Americans are infected with hepatitis C, but most are unaware they have it. Left untreated, the disease can progress to advanced stages, including liver cancer and death. Laboratory testing can identify infection in early stages, when treatment may be curative. In 2020, the CDC recommended one-time hepatitis C testing for all individuals aged 18 years of age or older, and that all pregnant women be tested for HCV during each pregnancy.

大约有200万美国人感染了丙型肝炎，但大多数人并不知道自己感染了丙型肝炎。如果不及时治疗，这种疾病可能会发展到晚期，包括肝癌和死亡。实验室检测可以在治疗可能治愈的早期阶段识别感染。2020年，疾病预防控制中心建议对所有18岁或以上的人进行一次性丙型肝炎检测，并在每次怀孕期间对所有孕妇进行丙型肝炎检测。

CDC also recommends routine periodic testing for people with risk factors..

CDC还建议对有危险因素的人进行常规定期检测。。

Quest is a leading provider of hepatitis testing services, with a comprehensive test menu of hepatitis screening and monitoring assays. In addition, Quest has the largest private laboratory database, with more than 60 billion data points. The company routinely develops research, called Quest Diagnostics Health Trends®, based on this data with the CDC and academic experts..

Quest是肝炎检测服务的领先提供商，拥有肝炎筛查和监测分析的综合测试菜单。此外，Quest拥有最大的私人实验室数据库，拥有600多亿个数据点。该公司根据CDC和学术专家的这些数据，定期开展名为Quest Diagnostics Health Trends®的研究。。

In June 2023, the CDC, published an MMWR report based on Quest Diagnostics Health Trends data that found only one in three adults with evidence of hepatitis C viral infection have achieved viral clearance, despite the availability of curative therapies. Other Quest-CDC research collaborations have focused on the fentanyl drug crisis and HIV, as well as COVID-19 variant tracking using Quest's next-generation sequencing..

2023年6月，疾病预防控制中心根据Quest Diagnostics Health Trends数据发布了一份MMWR报告，该报告发现，尽管有治疗方法，但有丙型肝炎病毒感染证据的成年人中只有三分之一达到了病毒清除率。其他Quest-CDC研究合作的重点是芬太尼药物危机和艾滋病毒，以及使用Quest的下一代测序进行COVID-19变异追踪。。

About Quest Diagnostics

关于Quest Diagnostics

Quest Diagnostics empowers people to take action to improve health outcomes. Derived from the world's largest database of clinical lab results, our diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve health care management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the United States, and our nearly 50,000 employees understand that, in the right hands and with the right context, our diagnostic insights can inspire actions that transform lives.

Quest Diagnostics使人们能够采取行动改善健康状况。我们的诊断见解源自世界上最大的临床实验室结果数据库，揭示了识别和治疗疾病，激发健康行为和改善医疗保健管理的新途径。Quest每年为三分之一的成年美国人和美国一半的医生和医院提供服务，我们的近50000名员工明白，在正确的手中和正确的背景下，我们的诊断见解可以激发改变生活的行动。

www.QuestDiagnostics.com..

www.QuestDiagnostics.com。。

SOURCE Quest Diagnostics

SOURCE Quest诊断